You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
30 December 2025 - SOFIE Biosciences, a US manufacturer and developer of radiopharmaceuticals, announced on Monday that the first patient has been dosed in one of its two Phase 3 clinical trials evaluating [18F]FAPI-74, a fluorine-18 labeled radiopha...
30 December 2025 - Swedish biotechnology company Diamyd Medical AB (Nasdaq First North Growth Market:DMYD-B) said on Monday that it has reached alignment with the US Food and Drug Administration (FDA) to accelerate the primary efficacy readout in its...
30 December 2025 - Biotechnology company INOVIO (NASDAQ:INO) announced on Monday that the US Food and Drug Administration (FDA) has accepted its Biologics License Application (BLA) for INO-3107 for review as a potential treatment for adults with Recu...
29 December 2025 - Tri-City Cardiology, a Phoenix, Arizona-based cardiology group, announced on Friday that it has added Dr. Olubadewa A. Fatunde and Dr. Umashankar Lakshmanadoss to its care team.Dr. Fatunde is joining San Tan Valley and Pecos clinic...
29 December 2025 - ABL Bio, a South Korean company specialising in bispecific antibodies, announced on Friday that it will receive an upfront payment of USD40m for a licence, research and collaboration agreement for its Grabody platform, and an equit...
29 December 2025 - Chinese biopharmaceutical company Harbour BioMed (HKEX:02142) announced on Sunday that it has entered into a long-term strategic collaboration with Yantai Lannacheng Biotechnology Co Ltd, a clinical-stage biotechnology company focu...
24 December 2025 - Precision oncology company Repare Therapeutics Inc (Nasdaq: RPTX) announced on Wednesday that it has entered into a definitive asset purchase agreement with Gilead Sciences Inc for the sale of its polymerase theta ATPase inhibitor ...